We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

95 hedge funds and large institutions have $254M invested in Cytokinetics in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 40 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more call options, than puts

Call options by funds: $1.35M | Put options by funds: $919K

36% more capital invested

Capital invested by funds: $187M → $254M (+$66.6M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

13% less funds holding

Funds holding: 109 → 95 (-14)

40% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 40

62% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 21

Holders
95
Holders Change
-14
Holders Change %
-12.84%
% of All Funds
2.53%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
8
Increased
24
Reduced
40
Closed
21
Calls
$1.35M
Puts
$919K
Net Calls
+$433K
Net Calls Change
-$2.64M

Top Buyers

1
WA
Wasatch Advisors
Utah
+$10.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.75M
3
BI
BVF Inc
California
+$5.32M
4
ACA
Avoro Capital Advisors
New York
+$4.13M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.75M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$7.3M
2
SFM
Sphera Funds Management
Israel
-$2.54M
3
EI
EAM Investors
California
-$2.16M
4
MCM
Matarin Capital Management
New York
-$1.86M
5
Invesco
Invesco
Georgia
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
EA
26
Emerald Acquisition
Washington
$1.22M +$1.05M +128,133 New
PAI
27
Palo Alto Investors
California
$1.17M – – –
BA
28
BlackRock Advisors
Delaware
$1.16M -$15.8K -1,930 -2%
TCIM
29
TIAA CREF Investment Management
New York
$1.03M -$115K -14,075 -11%
Goldman Sachs
30
Goldman Sachs
New York
$976K +$844K +102,839 New
HVC
31
Healthcare Value Capital
New Jersey
$949K – – –
CAM
32
ClariVest Asset Management
California
$847K +$98.5K +12,000 +16%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$785K – – –
PAM
34
Panagora Asset Management
Massachusetts
$729K -$1.15M -140,211 -65%
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
$674K -$20.2K -2,467 -3%
SO
36
STRS Ohio
Ohio
$615K +$41K +5,000 +8%
Deutsche Bank
37
Deutsche Bank
Germany
$599K -$382K -46,531 -42%
Charles Schwab
38
Charles Schwab
California
$542K – – –
Prudential Financial
39
Prudential Financial
New Jersey
$527K -$1.16M -141,162 -72%
TA
40
Teachers Advisors
New York
$486K – – –
Ohio Public Employees Retirement System (OPERS)
41
Ohio Public Employees Retirement System (OPERS)
Ohio
$485K +$266K +32,360 +173%
MCM
42
Matarin Capital Management
New York
$424K -$1.86M -226,810 -84%
KeyBank National Association
43
KeyBank National Association
Ohio
$419K – – –
Two Sigma Advisers
44
Two Sigma Advisers
New York
$417K -$191K -23,300 -35%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$386K -$20.5K -2,501 -6%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$371K -$157K -19,164 -33%
SFM
47
Sphera Funds Management
Israel
$304K -$2.54M -309,875 -91%
VEA
48
Virtus ETF Advisers
New York
$279K +$59.5K +7,255 +33%
MLICM
49
Metropolitan Life Insurance Company (MetLife)
New York
$261K – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$251K +$71.4K +8,700 +49%
1
2
3 4 5

CYTK Hedge Fund Activity: Q2 2016 in Review

95 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2016, worth a combined $254M — up 36% from $187M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of CYTK and 8 opened new positions — a net loss of 13 holders — while 40 trimmed existing stakes and 24 added.

The largest buyer was Wasatch Advisors, adding an estimated $10.4M. The largest seller was Acadian Asset Management, cutting an estimated $7.3M.

  • 95 institutional investors held Cytokinetics (CYTK) as of Q2 2016, down from 109 in Q1 2016.
  • Funds reported $254M of Cytokinetics stock for Q2 2016, up 36% quarter-over-quarter.
  • 8 funds opened new Cytokinetics positions in Q2 2016 and 21 closed out, a net change of -13 holders.
  • The largest Cytokinetics buyer in Q2 2016 was Wasatch Advisors, an estimated $10.4M added.
  • The largest Cytokinetics seller in Q2 2016 was Acadian Asset Management, an estimated $7.3M sold.

Based on aggregated 13F filings for Q2 2016.